Robert Wainblat

Robert Wainblat is an experienced professional in business insights and analytics, currently serving as Associate Director at Takeda since June 2021, specializing in rare disease commercial and sales analytics. Wainblat has been recognized with the 2023 "One Takeda" Corporate Award. Prior roles include Senior Manager and Manager at Sanofi, focusing on oncology analytics, and consultant positions at BluePrint Research Group and Align Strategy, where Wainblat focused on market research and product strategy for various therapeutic areas. Additional experience includes a Senior Business Analyst role at C1 Consulting and prior roles at IMS Health. Wainblat holds a Bachelor of Science degree in Chemistry with a concentration in Pharmacology and a minor in Asian and Middle Eastern Studies from Duke University.